Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

market news

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
(FSLR) - Analyzing First Solar's Short Interest
Via Benzinga
Tickers FSLR
4 Perfect Costco Gifts for the Person Who Has Everything
Via The Motley Fool
Tickers COST
Which stocks are moving before the opening bell on Monday?
Via Chartmill
Is BROWN & BROWN INC (NYSE:BRO) suited for quality investing?
Via Chartmill
Tickers BRO
Robinhood Jumps On Upgrade, 'More Room To Run' Postelection, Analyst Says
Via Investor's Business Daily
Tickers HOOD SCHW
OPEC+ may extend output cuts to prevent oil glut: UBS
Via Talk Markets
Topics Commodities
Tickers BNO OIL UBS UCO
What's Going On With Semler Scientific Stock Monday?
Via Benzinga
Tickers SMLR
NVENT ELECTRIC PLC is showing promising signs of setting up for a breakout.
Via Chartmill
(ONTO) - Analyzing Onto Innovation's Short Interest
Via Benzinga
Tickers ONTO
Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies
Via Benzinga
Tickers SAVA
Decibel Cannabis Raises $1.18M, Secures Capital For AgMedica BioScience Integration
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tickers DB DBCCF TSX-V:DB
EQT Secures $3.5 Billion Boost: Blackstone JV To Power Midstream Expansion
Via Benzinga
Tickers EQT FCG RSPG
S&P 500 Weekly Action Areas & Price Objectives - Monday, Nov. 25
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Tickers SPX
How Is The Market Feeling About Genpact?
Via Benzinga
Tickers G
'The Days Of Free Money Are Over': 2025 Real Estate Predictions From CRE's Top Ten Issues Report
Via Benzinga
(ARES) - Analyzing Ares Management's Short Interest
Via Benzinga
Tickers ARES
Top 3 Real Estate Stocks That May Explode In Q4
Via Benzinga
Tickers CMCT OPI WHLR
Smart Investors Are Avoiding 12-Month CDs, Even With Rates at 5%. Here's Why
Via The Motley Fool
BridgeBio Catapults After Snagging Approval For Pfizer-Rivaling Heart Drug
Via Investor's Business Daily
Tickers BBIO PFE
Amid Trump's 'Drill Baby, Drill' Pledge, Strategist Predicts US Oil Supply Will See 'Marginal' Increase: 'Does The World Need That Much Oil?'
Via Benzinga
Topics Government
Exposures Political
Tickers OILU UCO XOP
Positive Start To A Short Week
Via Talk Markets
Topics Stocks / Equities
Tickers SPX
This Nio Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Tickers AJG FIVE HCA MTB
What to Expect from Nutanix's Earnings
Via Benzinga
Tickers NTNX
Insights Ahead: Nordstrom's Quarterly Earnings
Via Benzinga
Tickers JWN
Insights into Kohl's's Upcoming Earnings
Via Benzinga
Tickers KSS
An Overview of JM Smucker's Earnings
Via Benzinga
Tickers SJM
A Look Ahead: Arrowhead Pharma's Earnings Forecast
Via Benzinga
Tickers ARWR
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Via Benzinga
Exposures Product Safety
Tickers BAYRY BBIO PFE
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
Via Benzinga
Tickers MUSA
Earnings Outlook For CrowdStrike Holdings
Via Benzinga
Tickers CRWD
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.